MINNEAPOLIS, April 10, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc (PBLA)., a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with ...
This poster provides an overview of the current subset-based nomenclature for T cells and a newly proposed modular nomenclature for T cells. It is based on the 2025 consensus statement Guidelines for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results